Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam to Treat Moderate-to-Severe Acne Pharmaceutical Investing
Pivot Completes C$1.1 Million Non-Brokered Private Placement and Loan Facility Pharmaceutical Investing
Zealand Pharma Doses First Patient in Phase 3 Trial with Dasiglucagon for Treatment of Congenital Hyperinsulinism Pharmaceutical Investing
Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy Pharmaceutical Investing
Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia Pharmaceutical Investing
Kura Oncology Announces FDA Clearance of Investigational New Drug Application for Menin-MLL Inhibitor KO-539 Biotech Investing
Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance Pharmaceutical Investing
Canntab Discusses Hemp Supply Agreement with FSD Pharma and Canada’s Second Wave of Cannabis Legalization Cannabis Investing News
